20 years of obesity treatment: New guidelines, semaglutide among the biggest advances - Healio

During the past 2 decades, Endocrine Today has reported on the latest developments in treating obesity. For its 20th year, the publication is taking a look back.Two decades ago, evidence-based care for obesity was in its early stages. The field was less than …

Source/Disclosures Source: Healio interviews Disclosures: Apovian reports serving on advisory boards for Abbott Nutrition, Allergan, Altimmune, Bariatrix Nutrition, Cowen and Co., Curavit Clini… [+10448 chars]

full article...